We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Axa | EU:CS | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.28 | -0.83% | 33.41 | 33.40 | 33.41 | 33.57 | 33.39 | 33.56 | 223,469 | 09:09:31 |
From May 2019 to May 2024
By Nathan Allen
AXA SA (CS.FR) said Wednesday that it has received an "irrevocable offer" from U.S. private-equity firm Cinven Group Ltd. for its AXA Life Europe business that could potentially generate cash proceeds of 1.17 billion euros ($1.37 billion).
The proceeds would include EUR925 million from the sale of shares in AXA Life Europe, and a further EUR240 million that AXA Life Europe would pay to AXA SA via capital distribution prior to the deal's close, the company said.
AXA Life Europe is a specialized platform that designed, manufactured and distributed AXA's Variable Annuity products across Europe. It posted underlying earnings of EUR19 million in the 2017 fiscal year, the company said.
The deal is subject to regulatory approval and should be finalized by the end of 2018 or early 2019, according to the multinational insurance company.
Write to Nathan Allen at nathan.allen@dowjones.com
(END) Dow Jones Newswires
August 01, 2018 12:22 ET (16:22 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Axa Chart |
1 Month Axa Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
